Methodologies for conducting trials and other studies, including data handling and analysis at ESTRO-EORTC workshop
26 Apr 2017
The EORTC contributes to ESTRO 36, Europe’s largest conference in radiation oncology in Vienna, Austria on Friday, May 5th with a pre-congress course/workshop which will be held from 13.30 – 18.00 in Galleria 11-12.
The workshop will be chaired by Denis Lacombe (EORTC Director General) and Vincent Grégoire (Chair of the Head and Neck Group and member of the Radiation Oncology Group).
Our workshop offers the opportunity to learn from experts about current views on conducting radiation oncology studies as well as data handling and analysis, building from the past into the future.
Laurence Collette (Belgium), an expert in statistics, clinical trials and epidemiology will explain the specificities of radiotherapy studies; which designs and endpoints are preferably used or not.
Michael Baumann (Germany), a radiation oncologist specialized in thoracic tumours, head & neck cancer, and translational radiation oncology will talk about studies with new radiation technologies.
Eric Deutsch (France), Head of the Radiotherapy Department of Gustave Roussy Cancer Campus in Paris, will detail the methodological aspects of studies using the combination of medication and radiation.
After the break, recycling of old studies will be discussed. It will be explained how data from the past can be used to inform about current treatments:
Maja Maraldo (Denmark), a resident in clinical oncology, will illustrate this by means of her experience in lymphoma.
Mirjam Mast (The Netherlands), experienced in research & development in radiotherapy, will share her experience in early breast cancer.
Conny Vrieling (Switzerland), a radiation oncologist, will talk about the outcome after first local failure in early breast cancer, in long-term survivors of radiation.
This session will be closed with a discussion with all speakers.
Related News
Meet the new EORTC Board
9 Jul 2024
We are pleased to announce the release of the EORTC 2023 Annual Report
17 Jun 2024
Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group
24 May 2024
Clinical Trials Day 2024: a Q&A on pragmatic clinical trials
20 May 2024
EORTC/EMA workshop suggests an international way forward for treatment optimisation studies
8 May 2024
EORTC’s Participation at the ESTRO Congress 2024
29 Apr 2024
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024